|
|
||||||||
Ann Thorac Surg 2006;81:2281-2283
© 2006 The Society of Thoracic Surgeons
Department of Cardiac Surgery, Vanderbilt University, Nashville, Tennessee
Accepted for publication July 5, 2005.
* Address correspondence to Dr Shah, Pediatric Cardiac Surgery, 5247 Doctor's Office Tower, 2200 Children's Way, Nashville, TN 37232-9292 (Email: salman1997{at}yahoo.com).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Case Reports |
|---|
|
|
|---|
He was admitted and initially started on continuous positive pressure ventilation along with inhaled albuterol breathing treatments and oxygen. Cardiac catheterization revealed normal Fontan pressures with a patent fenestration and good flow to both lungs.
During the course of his hospitalization he started coughing and expectorated bronchial casts again. A chest tube was placed for a pleural effusion, but his clinical situation did not improve. He had been started on inhaled tissue plasminogen activator as well as corticosteroids. Despite adequate medical management he deteriorated and had to be intubated. Bronchoscopy at this time revealed thick multiple casts in the tracheobronchial tree. His overall condition worsened and he required veno-venous extracorporeal membrane oxygenation support. With vigorous medical management his condition improved and he was weaned off of extracorporeal membrane oxygenation support. At that time a decision was made to proceed to the operating room to ligate his thoracic duct, hypothesizing that this would decrease the lymphatic pressure in his chest and hopefully eliminate the production of bronchial casts. Mass ligation of the thoracic duct was done just above the esopahageal hiatus through a right posterolateral thoracotomy. His condition slowly improved and he was extubated. His pleural effusions persisted and he ultimately required a chemical doxycycline pleurodesis. He was discharged home on nasal cannula oxygen (0.5 L). He has been followed-up for 5 months after thoracic duct ligation and has remained free from any episodes of plastic bronchitis.
Patient 2
A patient who had been born with double inlet left ventricle underwent a modified right Blalock-Taussig shunt shortly after birth. Subsequently he underwent a bidirectional Glenn with shunt takedown and then had a completion Fontan done. He remained healthy for the next 3 years and then started to have repeated episodes of coughing up bronchial casts, consistent with plastic bronchitis. He was managed medically with no success, and after multidisciplinary discussions a decision was made to proceed with a thoracic duct ligation. Perioperative cream was given to make the duct prominent. A mass ligation of the thoracic duct was done through a right thoracotomy.
The patient did well after his surgery and had an uneventful postoperative course. He has been followed-up for 2 years since the thoracic duct ligation and has remained free of any further episodes of cast expectoration related to plastic bronchitis.
| Comment |
|---|
|
|
|---|
The Fontan physiology renders patients susceptible to the development of chronic pleural effusions, chylothorax, atrial arrythmias, protein losing enteropathy, and plastic bronchitis [13]. A decline in cardiac function, elevated pulmonary vascular resistance, and high venous pressures are believed to play a role in the development of some of these conditions.
Plastic bronchitis also known as cast bronchitis is a rare clinical entity that is characterized by the formation of intrabronchial casts [9]. These casts vary from being stringy or rubbery to firm, thick, and hard. In addition to occurring in congenital cardiac disease, this condition can also occur in the setting of asthma, sickle cell disease [10], cystic fibrosis, smoke inhalation, and pulmonary infections [1].
These casts have been classified as type I (inflammatory) or type II (acellular) [11]. The inflammatory casts occur in the setting of underlying pulmonary inflammatory disease, whereas acellular casts are seen more commonly with underlying congneital cardiac disease. Type I casts are believed to occur due to increased mucin production in the setting of poor clearance mechanisms. The cause of type II casts remains unclear.
Declining ventricular function, the presence of a high central venous pressure with high intrathoracic lymphatic pressures and bronchial hypersecretions may be the underlying causes, although these cannot be demonstrated objectively and repeatedly in all patients [12]. Hug and colleagues [8] demonstrated leakage of chyle into the alveoli in a fatal case of plastic bronchitis, substantiating the hypothesis that high intrathoracic lymphatic pressure or obstruction to lymph flow leads to the development of lympho-alveolar fistulae and development of bronchial casts.
Patients usually present with dyspnea increased work of breathing and repeated episodes of coughing and expectoration of casts. Chest roentgenogram usually reveals an infiltrate with atelectasis. The casts can cause severe respiratory embarrassment with asphyxia, cardiac arrest, and death. Mortality has been reported to be as high as 29% in patients with underlying congenital cardiac condition [1].
Different therapies have been explored [47]. Inhaled corticosteroids have reported benefit with inflammatory casts, but are not as successful with acellular casts that are more frequent in the setting of congenital heart disease. Inhaled tissue plasminogen activators [13] and inhaled heparin have been used with success in loosening of the casts and facilitating expectoration. Inhaled low dose azithromycin has been reported to result in clinical, spirometric, and radiologic improvement [6]. Similarly inhaled rh-DNAse has been of reported benefit in plastic bronchitis in the setting of acute chest syndrome with sickle cell disease [14]. Repeated toilet bronchoscopies are sometimes required to remove thick tenacious casts [4]. However none of these treatments result in a cure and usually provide short-term symptomatic relief. Improvement in underlying cardiac function and decrease in central venous pressure would theoretically improve the condition. This can be inferred from the success of fenestration of the Fontan circuit [15] and cardiac transplantation in the management of protein-losing enteropathy secondary to failing Fontan circulation [16]. Patients with a failing Fontan circulation who develop plastic bronchitis have also been reported to gain benefit from atrial pacing and restoration of atrioventricular synchrony [17].
The lack of an available, definitive long-term solution and the failure of medical management led us to try thoracic duct ligation as a surgical option. With both patients this was done through a right thoracotomy with mass ligation of all tissues to the right of the esophagus and the aorta and overlying the vertebral column.
Plastic bronchitis is a rare complication of patients having undergone the Fontan operation. Expectoration of casts with the associated airway obstruction is a distressing problem for both the patient and their parents. Rare occurrence combined with an unclear cause has made the management of this problem difficult and frustrating. Palliative management with various inhaled therapies mainly serves to soften the casts and helps with expectoration. This led us to consider a surgical solution in the form of a thoracic duct ligation. The theoretical advantage of this was to decrease intrathoracic lymph flow and pressure, which was believed to be contributing to the development of the bronchial casts. Thoracic duct ligation was attempted in 2 patients who had plastic bronchitis develop after the Fontan operation. In both these patients the surgery was successful and no recurrence of cast formation or expectoration has been reported to date.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. R. Griffiths, A. K. Kaza, M. C. Wyler von Ballmoos, H. Loyola, A. M. Valente, E. D. Blume, and P. del Nido Evaluating failing Fontans for heart transplantation: predictors of death. Ann. Thorac. Surg., August 1, 2009; 88(2): 558 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nayar, R. Parmar, S. Kulkarni, and K. M. Cherian Treatment of Plastic Bronchitis Ann. Thorac. Surg., May 1, 2007; 83(5): 1884 - 1886. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |